• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Benzinga Pro's Top 5 Stocks To Watch For Thursday, Apr. 14, 2022: TWTR, LI, SFET, NNVC, KLDO

    4/14/22 9:07:12 AM ET
    $KLDO
    $LI
    $NNVC
    $SFET
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Auto Manufacturing
    Industrials
    Get the next $KLDO alert in real time by email

    Today's 5 Stock Ideas:

    • Twitter (TWTR) - Shares were up ~6% near the $49 level following news Elon Musk made an offer to buy all of the company at $54.20 per share in cash. Analysts were mixed on the news; a Wedbush analyst, Dan Ives, was optimistic the offer would be accepted while another analyst voiced concern about Elon Musk walking away from the company if his offer was rejected.

    • Li Auto (LI) - A potential sympathy play following a report the CEO of peer in the Chinese electric vehicle space, XPeng (XPEV), warned all Chinese vehicle factories may have to stop production in May if supply chain disruption continues.

    • Safe-T Group (SFET) - A play on cybersecurity. Stocks in the group were on watch Wednesday following reports U.S. officials said advanced hackers have shown the ability to hijack multiple industrial control systems.

    • NanoViricides (NNVC) - A play on current fears related to bird flu contagion.

    • Kaleido Biosciences (KLDO) - One of Thursday morning's biggest winners. The company is a low-float penny-stock play. Shares closed up 75% on Wednesday and were up another 30% Thursday morning.

     

     

    Benzinga programming note: we've started a podcast for the Stocks To Watch alert! Click here to see all the episodes.

    Hosted by the Benzinga Pro newsdesk's Brent Slava and Steve Krause, the podcast will give more in-depth information on the ideas presented in the daily Stocks To Watch alert!

    Listeners can find the podcast on Spotify and Apple by searching "Benzinga Stocks To Watch."

    Get the next $KLDO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $KLDO
    $LI
    $NNVC
    $SFET

    CompanyDatePrice TargetRatingAnalyst
    Li Auto Inc.
    $LI
    3/17/2026$19.00Buy → Neutral
    Goldman
    Li Auto Inc.
    $LI
    2/9/2026$14.00Neutral → Underweight
    Analyst
    Li Auto Inc.
    $LI
    1/23/2026$17.50Buy → Hold
    Jefferies
    NanoViricides Inc.
    $NNVC
    12/16/2025Buy
    Alliance Global Partners
    Li Auto Inc.
    $LI
    12/4/2025$18.60Buy → Hold
    HSBC Securities
    Li Auto Inc.
    $LI
    12/1/2025$18.50Buy → Hold
    China Renaissance
    Li Auto Inc.
    $LI
    11/11/2025$19.00Neutral
    Piper Sandler
    Li Auto Inc.
    $LI
    9/3/2025$30.50Outperform → Buy
    Daiwa Securities
    More analyst ratings

    $KLDO
    $LI
    $NNVC
    $SFET
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Li Auto Inc. Announces Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Quarterly total revenues reached RMB28.8 billion (US$4.1 billion)1Quarterly deliveries were 109,194 vehiclesFull year total revenues reached RMB112.3 billion (US$16.1 billion)Full year deliveries were 406,343 vehicles BEIJING, China, March 12, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter and full year ended December 31, 2025. Operating Highlights for the Fourth Quarter of 2025 and Full Year 2025 Total deliveries for the fourth quarter of 2025 were 109,194 vehicles, representing a 31.2% year-over-year decrease.              FY 2025

    3/12/26 4:30:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto Inc. February 2026 Delivery Update

    BEIJING, China, March 01, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it delivered 26,421 vehicles in February 2026. As of February 28, 2026, Li Auto's cumulative deliveries reached 1,594,304. Li Auto officially rolled out OTA update version 8.3 ahead of the Chinese Spring Festival, featuring comprehensive upgrades in three key areas: VLA Driver large model, smart cockpit and smart electric functionality. During the Spring Festival travel peak, the Company provided users with a stable and convenient energy replenishment experience through its nationwide network of more than

    2/28/26 9:00:00 PM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    BEIJING, China, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 before the U.S. market opens on Thursday, March 12, 2026. The Company's management will hold an earnings conference call on Thursday, March 12, 2026, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will

    2/27/26 4:00:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $KLDO
    $LI
    $NNVC
    $SFET
    SEC Filings

    View All

    SEC Form 6-K filed by Li Auto Inc.

    6-K - Li Auto Inc. (0001791706) (Filer)

    3/12/26 9:26:14 AM ET
    $LI
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Li Auto Inc.

    6-K - Li Auto Inc. (0001791706) (Filer)

    3/2/26 7:07:28 AM ET
    $LI
    Auto Manufacturing
    Industrials

    SEC Form 6-K filed by Li Auto Inc.

    6-K - Li Auto Inc. (0001791706) (Filer)

    2/27/26 4:02:05 PM ET
    $LI
    Auto Manufacturing
    Industrials

    $KLDO
    $LI
    $NNVC
    $SFET
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    September 7, 2021 - Coronavirus (COVID-19) Update: September 7, 2021

    For Immediate Release: September 07, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As part of the FDA’s effort to protect consumers, the agency issued a warning letter to Kaleido Biosciences, Inc. for not complying with federal laws and regulations, including laws and regulations to protect individuals participatin

    9/7/21 4:11:11 PM ET
    $KLDO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $KLDO
    $LI
    $NNVC
    $SFET
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by Li Auto Inc.

    3 - Li Auto Inc. (0001791706) (Issuer)

    3/18/26 8:15:53 AM ET
    $LI
    Auto Manufacturing
    Industrials

    SEC Form 3 filed by Li Auto Inc.

    3 - Li Auto Inc. (0001791706) (Issuer)

    3/18/26 8:16:32 AM ET
    $LI
    Auto Manufacturing
    Industrials

    SEC Form 3 filed by Li Auto Inc.

    3 - Li Auto Inc. (0001791706) (Issuer)

    3/18/26 8:16:11 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $KLDO
    $LI
    $NNVC
    $SFET
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Li Auto downgraded by Goldman with a new price target

    Goldman downgraded Li Auto from Buy to Neutral and set a new price target of $19.00

    3/17/26 7:56:17 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto downgraded by Analyst with a new price target

    Analyst downgraded Li Auto from Neutral to Underweight and set a new price target of $14.00

    2/9/26 7:00:29 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto downgraded by Jefferies with a new price target

    Jefferies downgraded Li Auto from Buy to Hold and set a new price target of $17.50

    1/23/26 8:13:46 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $KLDO
    $LI
    $NNVC
    $SFET
    Financials

    Live finance-specific insights

    View All

    Li Auto Inc. Announces Unaudited Fourth Quarter and Full Year 2025 Financial Results

    Quarterly total revenues reached RMB28.8 billion (US$4.1 billion)1Quarterly deliveries were 109,194 vehiclesFull year total revenues reached RMB112.3 billion (US$16.1 billion)Full year deliveries were 406,343 vehicles BEIJING, China, March 12, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter and full year ended December 31, 2025. Operating Highlights for the Fourth Quarter of 2025 and Full Year 2025 Total deliveries for the fourth quarter of 2025 were 109,194 vehicles, representing a 31.2% year-over-year decrease.              FY 2025

    3/12/26 4:30:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 12, 2026

    BEIJING, China, Feb. 27, 2026 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced that it will report its unaudited financial results for the fourth quarter and full year 2025 before the U.S. market opens on Thursday, March 12, 2026. The Company's management will hold an earnings conference call on Thursday, March 12, 2026, at 8:00 A.M. U.S. Eastern Time or 8:00 P.M. Beijing/Hong Kong Time on the same day. For participants who wish to join the call, please complete online registration using the link provided below prior to the scheduled call start time. Upon registration, participants will

    2/27/26 4:00:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    Li Auto Inc. Announces Unaudited Third Quarter 2025 Financial Results

    Quarterly total revenues reached RMB27.4 billion (US$3.8 billion)1Quarterly deliveries reached 93,211 vehicles BEIJING, China, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Li Auto Inc. ("Li Auto" or the "Company") (NASDAQ:LI, HKEX: 2015)), a leader in China's new energy vehicle market, today announced its unaudited financial results for the quarter ended September 30, 2025. Operating Highlights for the Third Quarter of 2025 Total deliveries for the third quarter of 2025 were 93,211 vehicles, representing a 39.0% year-over-year decrease.   2025 Q3 2025 Q2 2025 Q1 2024 Q4 Deliveries 93,211 111,074 92,864 158,696             2024 Q3 2024 Q2 2024 Q1 2023 Q4 Deliveries 152,831 108,581 80,400 131,805   

    11/26/25 3:45:00 AM ET
    $LI
    Auto Manufacturing
    Industrials

    $KLDO
    $LI
    $NNVC
    $SFET
    Leadership Updates

    Live Leadership Updates

    View All

    Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline

    The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific antibody and antibody-drug conjugate (ADC) therapeutics, today announced the successful completion of a $42 million Series A financing. The financing round was led by Lanchi Ventures, a preeminent global early-stage technology investor known for backing breakthrough innovations, with participation from an elite syndicate of new investors including Yuanbio Venture Capital, Legend Capital and C&D Eme

    11/28/24 8:06:00 AM ET
    $BZ
    $HUYA
    $LI
    Computer Software: Programming Data Processing
    Technology
    Auto Manufacturing
    Industrials

    Alltrna Appoints Rare Disease Clinical Research Expert, Dr. Anne Pariser, as Vice President, Medical and Regulatory Affairs

    CAMBRIDGE, Mass., Feb. 28, 2022 /PRNewswire/ -- Alltrna, a Flagship Pioneering company unlocking transfer RNA (tRNA) biology and pioneering tRNA therapeutics to regulate the protein universe and resolve disease, today announced the appointment of Anne Pariser, M.D., as Vice President, Medical and Regulatory Affairs. Prior to joining Alltrna, Dr. Pariser was the Director of the Office of Rare Diseases Research (ORDR) at the National Center for Advancing Translational Sciences (NCATS), National Institutes of Health (NIH), whose mission is to advance rare diseases research through a variety of research programs. Prior to ORDR, she worked at the U.S. Food and Drug Administration (FDA) Center for

    2/28/22 9:00:00 AM ET
    $AXLA
    $CDAK
    $DNLI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medicinal Chemicals and Botanical Products
    Biotechnology: Pharmaceutical Preparations

    INVAIO SCIENCES STRENGTHENS ITS BOARD OF DIRECTORS WITH THE APPOINTMENT OF HUGH GRANT

    CAMBRIDGE, Mass., Feb. 15, 2022 /PRNewswire/ -- Invaio Sciences, Inc., a Flagship Pioneering company focused on unlocking the potential of the planet's interdependent natural systems to solve pressing agricultural, sustainability, and environmental challenges, today announced the appointment of Hugh Grant to its Board of Directors. Grant brings nearly 40 years of agricultural and corporate leadership, including as Chairman, President, and Chief Executive Officer of the former Monsanto Company, a global provider of technology-based solutions and agricultural products. During h

    2/15/22 10:05:00 AM ET
    $AXLA
    $CDAK
    $DNLI
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Medicinal Chemicals and Botanical Products
    Biotechnology: Pharmaceutical Preparations

    $KLDO
    $LI
    $NNVC
    $SFET
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by Safe-T Group Ltd. (Amendment)

    SC 13G/A - Alarum Technologies Ltd. (0001725332) (Subject)

    1/16/24 7:00:16 AM ET
    $SFET
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Safe-T Group Ltd. (Amendment)

    SC 13G/A - Alarum Technologies Ltd. (0001725332) (Subject)

    1/16/24 7:00:15 AM ET
    $SFET
    Computer Software: Prepackaged Software
    Technology

    SEC Form SC 13G/A filed by Safe-T Group Ltd. (Amendment)

    SC 13G/A - Alarum Technologies Ltd. (0001725332) (Subject)

    2/8/23 11:15:11 AM ET
    $SFET
    Computer Software: Prepackaged Software
    Technology